Total medical devices industry M&A deals in Q2 2020 worth $1.78bn were announced in the US, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked a decrease of 7.9% over the previous quarter and a drop of 71.3% when compared with the last four-quarter average of $6.19bn.

The US held a 79.05% share of the global medical devices industry M&A deal value that totalled $2.25bn in Q2 2020.

In terms of deal activity, the US recorded 48 deals during Q2 2020, marking a drop of 15.8% over the previous quarter and a drop of 11.1% over the last four-quarter average.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The US medical devices industry M&A deals in Q2 2020: Top deals

The top five medical devices industry M&A deals accounted for 98.6% of the overall value during Q2 2020.

The combined value of the top five medical devices M&A deals stood at $1.75bn, against the overall value of $1.78bn recorded for the month.

The top five medical devices industry deals of Q2 2020 tracked by GlobalData were:

1) InVitae’s $1.4bn acquisition of ArcherDx

2) The $200m asset transaction with CareZone by Walmart

3) LeMaitre Vascular’s $90m acquisition of Artegraft

4) The $31m acquisition of UrSure by OraSure Technologies

5) My Next Health’s asset transaction with for $30m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.